- Home
- SEIC vs ELAN Comparison
SEIC vs ELAN Comparison
Compare SEIC & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SEIC | ELAN |
|---|---|---|
| Founded | 1968 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 12.4B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SEIC | ELAN |
|---|---|---|
| Price | $111.46 | $24.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $104.86 | $27.89 |
| AVG Volume (30 Days) | 569.5K | ★ 7.2M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ 27.66 | N/A |
| EPS | ★ 2.99 | 0.22 |
| Revenue | $2,297,381,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $14.61 | $8.21 |
| Revenue Next Year | $7.25 | $5.31 |
| P/E Ratio | ★ $36.50 | $112.18 |
| Revenue Growth | ★ 8.10 | 6.22 |
| 52 Week Low | $75.08 | $17.51 |
| 52 Week High | $112.15 | $27.98 |
Technical Indicators
Market Signals| Indicator | SEIC | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 68.83 | 50.40 |
| Support Level | $86.62 | $23.40 |
| Resistance Level | N/A | $25.77 |
| Average True Range (ATR) | 1.60 | 0.70 |
| MACD | -0.28 | 0.07 |
| Stochastic Oscillator | 81.85 | 53.98 |
Price Performance
Historical ComparisonAbout SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2025, SEI (including LSV) manages, administers, or advises about $1.9 trillion in assets.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.